Variant report
Variant | nsv1054577 |
---|---|
Chromosome Location | chr12:30391221-30409749 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IPO8-1 | chr12:30397268-30397338 | ENSG00000257756 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144587348 | chr12:30394062-30394063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs16905908 | chr12:30394083-30394084 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs545524471 | chr12:30394088-30394089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2163112 | chr12:30394157-30394158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546567499 | chr12:30394302-30394303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148041780 | chr12:30394325-30394326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529001854 | chr12:30394327-30394328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190305117 | chr12:30394336-30394337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570295918 | chr12:30394373-30394374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114371169 | chr12:30394409-30394410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1465601 | chr12:30394419-30394420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs571114175 | chr12:30394420-30394421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1465600 | chr12:30394432-30394433 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs553333318 | chr12:30394466-30394467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34950292 | chr12:30394479-30394480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs398098103 | chr12:30394485-30394486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199780310 | chr12:30394486-30394487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181185995 | chr12:30394506-30394507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535567300 | chr12:30394528-30394529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561412768 | chr12:30394540-30394541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74083212 | chr12:30394567-30394568 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs537923378 | chr12:30397277-30397278 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs2564581 | chr12:30397287-30397288 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs377162937 | chr12:30397288-30397289 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs146753240 | chr12:30404213-30404214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73280285 | chr12:30404235-30404236 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs184085325 | chr12:30404238-30404239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558537866 | chr12:30404244-30404245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188087662 | chr12:30404284-30404285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2054769 | chr12:30404286-30404287 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs570476321 | chr12:30404313-30404314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534825204 | chr12:30404334-30404335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73280289 | chr12:30404337-30404338 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs567829337 | chr12:30404357-30404358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4931303 | chr12:30404368-30404369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs73280293 | chr12:30404379-30404380 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs575452509 | chr12:30404400-30404401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181045758 | chr12:30404409-30404410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557803926 | chr12:30404412-30404413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559064756 | chr12:30404425-30404426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs16905931 | chr12:30404435-30404436 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs540359508 | chr12:30404449-30404450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561628780 | chr12:30404461-30404462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530361737 | chr12:30404465-30404466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1825527 | chr12:30404487-30404488 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs74468737 | chr12:30404488-30404489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563875500 | chr12:30404492-30404493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531124293 | chr12:30404503-30404504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1366937 | chr12:30404509-30404510 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs564166132 | chr12:30404538-30404539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30394000-30394600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr12:30404200-30404600 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr12:30404200-30404800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr12:30404200-30405200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr12:30404200-30405200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr12:30404400-30404800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr12:30404400-30404800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr12:30404400-30404800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr12:30404600-30405200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr12:30404800-30410200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr12:30405200-30410200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
12 | chr12:30405800-30408000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
13 | chr12:30406200-30406400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr12:30406400-30410400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr12:30409000-30409200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr12:30409200-30416400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |